Ventil Device Usefulness in Mechanically Ventilated ICU Patients

NCT ID: NCT04355754

Last Updated: 2020-04-27

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 40 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2020-04-15
• Study Completion Date: 2020-12-31

Brief Summary

During Covid-19 pandemic many patients require mechanical ventilation due to disastrous impact of SARS-CoV-2 on lungs. In several countries there is a shortage of ICU beds and ventilators. Critically ill patients are treated outside ICUs. Doctors are facing ethical dilemmas who they should treat with ventilation, who should receive ventilator and who should but will not. In ICUs or step down units or in nursery homes there are also patients beyond hope treated - very often they are dependent on mechanical ventilation. Some attempts to invent a device that could replace complex machines in patients with anticipated poor outcome have been made. Ventil was used in clinical scenarios for separate lung ventilation with good effect. As a flow divider it has a potential to ventilate 2 patients at the same time. In the study Ventil will ventilate one patient and instead of the second there will be an artificial lung. Tidal volumes, minute ventilation, PEEP set and final will be checked. Ppeak, Pmean, Pplat, Cdyn, airway resistance, EtCO2, Sat O2, HR, SAP, DAP will be monitored every 2 hrs, as well as blood-gas analysis (every 8 hrs).

Detailed Description

During Covid-19 pandemic many patients require mechanical ventilation due to disastrous impact of SARS-CoV-2 on lungs. In several countries there is a shortage of ICU beds and ventilators. Critically ill patients are treated outside ICUs. Doctors are facing ethical dilemmas who they should treat with ventilation, who should receive ventilator and who should but will not.

Before pandemic in ICUs there had always been patients who required mechanical ventilation because of extrapulmonary reasons as well as palliative cases or those in vegetative condition. Most of these patients require just a simple ventilator, not a sophisticated mode of ventilation. Some attempts to invent a device that could replace complex machines in patients with anticipated poor outcome have been made. Ventil was used in clinical scenarios for separate lung ventilation with good effect. VENTIL device, a flow divider, theoretically allows for independent, fully automated synchronous ventilation of 2 patients with use of only one respirator. In the shortage of respirators (ex. terrorist attack, natural disasters) device allows also to ventilate in classical system two patients using single respirator.

Ventil - independent lung ventilation system was constructed by engineers from Nalecz Institute of Biocybernetics and Biomedical Engineering of Polish Academy of Science. Ventil was tested in the clinical scenario - it's safety had been confirmed. Several years ago the working prototypes of the device, after approval of Ethical Committee, was tested in about 150 patients, who were ventilated with independent synchronous lung ventilation and had been found useful.

The idea of the study is to check the usefulness of the device (modern version) in ICU patients who can be ventilated with volume -controlled mode of ventilation as an attempt to use single device for ventilation of 2 patients. At this moment, according to several scientific societies, sharing mechanical ventilators should not be attempted because it cannot be done safely with current equipment. However, it is possible that using a designed flow divider will allow safe ventilation in patients without needs for complicated modes of ventilation. Then maybe it will be possible to release some ventilators and to use them in patients in severe condition, mainly in the era of extreme ventilator shortage. In the study Ventil will ventilate one patient and instead of the second, there will be an artificial lung. Tidal volumes, minute ventilation, PEEP set and final will be checked. Ppeak, Pmean, Pplat, Cdyn, airway resistance, EtCO2, Sat O2, HR, SAP, DAP will be monitored (every 2 hrs), as well as blood-gas analysis (every 8 hrs)

Conditions

Respiratory Insufficiency

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: OTHER
• Blinding Strategy: NONE

Study Groups

mechanically ventilated patients

Adult ICU patients who are mechanically ventilated and who do not require complex modes of ventilation.

A designated flow divider (Ventil) will be used to divide inspiratory gas flow from ventilator in two separate streams - one to the patient and the second to the artificial lung

Group Type: EXPERIMENTAL

Ventil - a gas flow divider

Intervention Type: DEVICE

Checking ventilation parameters set and obtained and clinical parameters while ventilating the patient and an artificial lung simultaneously, using inspiratory flow divider.

Interventions

Ventil - a gas flow divider

Checking ventilation parameters set and obtained and clinical parameters while ventilating the patient and an artificial lung simultaneously, using inspiratory flow divider.

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

• ICU patients who require mechanical ventilation

Exclusion Criteria

• Patients who require complex modes of ventilation will not be recruited

The sudy in an individual patient be discontinued if case of:

Respiratory Criteria:

• episodes of desaturation <90% (in pts without COPD) without reversibel reason
• need for FiO2 increase by 10%
• need for switch to other than CMV mode of ventillation
• need for neuromucular blockade or for deepen sedation because of assynchrony between patient and venilator
• cummulation of CO2>45 mm Hg (in pts without COPD) not responding to the increase of minute ventilation for 30 minutes
• Pplat >30 cmH2O

Circulatory criteria:

• New haemodynamic disturbances that cannot be explaned by other reasons

• ↑ or ↓of BP by 20%
• ↑ or ↓of HR by 20%
• clinically important heart rhythm disturbances

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Ministry of Science and Higher Education, Poland

OTHER_GOV

Sponsor Role: collaborator

Medical University of Gdansk

OTHER

Sponsor Role: lead

Responsible Party

Radoslaw Owczuk

full professor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Radoslaw Owczuk, prof

Role: PRINCIPAL_INVESTIGATOR

Medical University of Gdansk

Locations

Medical University of Gdansk

Gdansk, , Poland

Site Status: RECRUITING

Countries

Poland

Central Contacts

Radoslaw Owczuk, prof

Role: CONTACT

r.owczuk@gumed.edu.pl

+48583493270

Magdalena A Wujtewicz, dr

Role: CONTACT

magwuj@gumed.edu.pl

+48583493270

Facility Contacts

Magdalena A Wujtewicz

Role: primary

magwuj@gumed.edu.pl

+48583493357

Radoslaw Owczuk

Role: backup

r.owczuk@gumed.edu.pl

605408140

Other Identifiers

Ventil-COVID-19

Identifier Type: -

Identifier Source: org_study_id